Endo International PLC (ENDP)

ENDP (NASDAQ:Drugs) EQUITY
$8.72
pos +0.00
+0.00%
Today's Range: 8.56 - 8.88 | ENDP Avg Daily Volume: 6,389,600
Last Update: 08/18/17 - 4:00 PM EDT
Volume: 0
YTD Performance: -47.06%
Open: $0.00
Previous Close: $8.63
52 Week Range: $7.41 - $24.93
Oustanding Shares: 223,292,068
Market Cap: 1,927,010,547
6-Month Chart
TheStreet Ratings Grade for ENDP
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 4 5
Moderate Buy 0 0 0 0
Hold 11 10 10 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.47 2.43 2.43 2.29
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -0.44
Price Earnings Comparisons:
ENDP Sector Avg. S&P 500
-0.44 0.00 35.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-26.35% -61.90% -86.21%
GROWTH 12 Mo 3 Yr CAGR
Revenue 22.70 0.50 0.15
Net Income 0.00 5.00 0.00
EPS 0.00 1.50 0.00
Earnings for ENDP:
EBITDA 1.43B
Revenue 4.01B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $0.67 $0.71 $3.50 $3.09
Number of Analysts 8 8 11 11
High Estimate $0.71 $0.75 $3.61 $3.76
Low Estimate $0.63 $0.64 $3.35 $2.46
Prior Year $1.01 $1.77 $4.73 $3.50
Growth Rate (Year over Year) -33.91% -59.60% -25.91% -11.88%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.
There still will be winners and losers, but the new administration's FDA is a net plus for the industry.
There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.
As always, I am happy to stand in today for Doug Kass here at the Daily Diary.

3 Small Biotech Value Plays Real Money Pro($)

These stocks will be great stories in the second half of 2017, and are significantly undervalued.
Finding bullish and bearish reversals in the market.
We answer recent reader questions about three of the biotech stocks we regularly cover.
Not much action in the markets since our last update with the major indices continuing to grind slightly higher as we try to close out a solid…
Even among the losers, buys are scarce.
If you use TVIX and VXX put in an above-market limit order, or if you trade options buy calls on the VIX.

Columnist Conversations

Foot Locker's (FL) less than expected quarterly earnings set off a round of selling the entire athletic appare...
View Chart »  View in New Window » Gold has met the first upside target off the last setup zon...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.